This brand name is authorized in Estonia, Lithuania
The drug RIENSO contains one active pharmaceutical ingredient (API):
1
Ferumoxytol
UNII CLH5FT6412 - FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE
|
Ferumoxytol (USAN) is a dark-brown substance, which consists of nano-sized super paramagnetic iron (III)-oxide-cores coated with a small-sized carbohydrate shell of polyglucose sorbitol carboxymethylether (PSC). |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
B03AC | Iron trivalent, parenteral preparations | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EE | Ravimiamet | Identifier(s): 1588811, 1588822, 1598014, 1598025 |
Country: LT | Valstybinฤ vaistลณ kontrolฤs tarnyba | Identifier(s): 1066909, 1066910, 1068403, 1068404 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.